NSRX
Nasus Pharma
$3.09
−$0.03 (−0.96%)Jul 27, 2026
Key metrics
The numbers that frame NSRX today
- Market cap
- $27.86M
- P/E (TTM)
- -4.8
- EV / FCF
- -5.4
- ROIC
- 22,392.5%
- Div yield
- 0%
- Debt / equity
- 0.0
Growth
Revenue and earnings trend for NSRX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about NSRX
Is Nasus Pharma a good buy?
No. Nasus Pharma has poor quality. We think Nasus Pharma is selling at a very high price.
What is the market capitalization of NSRX?
Nasus Pharma's market capitalization is $27.86M.
What is the P/E ratio for NSRX stock?
Nasus Pharma's current P/E ratio is -4.8.
Does NSRX stock pay dividends?
Nasus Pharma does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for NSRX?
Nasus Pharma's Debt / Equity ratio is 0.04.